ABO Discrepancies Disclosure Objectives Importance Recognition ...
ABO Discrepancies Disclosure Objectives Importance Recognition ...
ABO Discrepancies Disclosure Objectives Importance Recognition ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
4/12/2011<br />
<strong>ABO</strong> <strong>Discrepancies</strong><br />
Developed by: Kelly Kezeor, MT(ASCP)<br />
Farai Tsimba-Chitsva, MT(ASCP)SBB<br />
Kerry Burright-Hittner, MT(ASCP)SBB<br />
<strong>Disclosure</strong><br />
I have no real or apparent conflict of interest or other<br />
relationships related to the content of this presentation.<br />
There is no off-label and/or investigational use of products<br />
discussed in this presentation. I have no relevant financial<br />
relationship to disclose.<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood ṬM<br />
<strong>Objectives</strong><br />
Correlate <strong>ABO</strong>/Rh testing with<br />
the expected result and define<br />
various ways to resolve an <strong>ABO</strong><br />
discrepancy.<br />
Identify various clerical l and<br />
technical errors that can affect<br />
<strong>ABO</strong>/Rh interpretation.<br />
Discuss the effects of disease<br />
on the expression of ABH<br />
antigens and antibodies.<br />
<strong>Importance</strong><br />
<strong>Recognition</strong> and resolution are two very<br />
important skills that blood bank<br />
technologists must possess.<br />
Of all the blood group systems, <strong>ABO</strong> is<br />
THE MOST IMPORTANT.<br />
<strong>ABO</strong> misinterpretation can lead to severe,<br />
if not fatal, transfusion complications in<br />
patients.<br />
What IS an <strong>ABO</strong> Discrepancy?<br />
Definition:<br />
When the results of the forward grouping<br />
(patient’s cells) does not correspond to the<br />
reverse grouping (patient’s plasma/serum).<br />
What CAUSES an <strong>ABO</strong> Discrepancy?<br />
Weak or Missing antigens in the<br />
FRONT type<br />
Weak or Missing antibodies in the<br />
REVERSE type<br />
Additional antigens in the<br />
FRONT type<br />
Additional antibodies in the<br />
REVERSE type<br />
1
4/12/2011<br />
<strong>ABO</strong> <strong>Discrepancies</strong> MUST be Resolved<br />
In PATIENTS, an <strong>ABO</strong> discrepancy must be<br />
resolved before ANY blood component is<br />
transfused.<br />
– If an <strong>ABO</strong> discrepancy cannot be resolved before<br />
blood product is needed, transfuse with Group O red<br />
blood cell units<br />
In DONORS, the discrepancy must be resolved<br />
before any blood is labeled with a blood type.<br />
Identify the Discrepancy<br />
Front Type<br />
Reverse Type<br />
Patient Anti-A Anti-B Anti-A,B A 1 cells B cells<br />
JK 0 3+ 3+ 0 0<br />
Front type: B<br />
Reverse Type: AB<br />
Theory: Weak reverse type<br />
Identify the Discrepancy<br />
Identify the Discrepancy<br />
Front Type<br />
Reverse Type<br />
Patient Anti-A Anti-B Anti-A,B A 1 cells B cells<br />
KK 4+ 4+ 4+ 3+ 3+<br />
Front Type<br />
Reverse Type<br />
Patient Anti-A Anti-B Anti-A,B A 1 cells B cells<br />
CK 4+ 0 4+ 0 4+<br />
Front Type: AB<br />
Reverse Type: O<br />
Front Type: A<br />
Back Type: A<br />
Theory: Additional antibodies in the reverse type<br />
Theory: NO DISCREPANCY NOTED<br />
Identify the Discrepancy<br />
Front Type<br />
Reverse Type<br />
Patient Anti-A Anti-B Anti-A,B A 1 cells B cells<br />
AK 0 w+ 1+ 4+ 0<br />
Front Type: B??<br />
Reverse Type: B<br />
Steps for Resolution<br />
Recheck specimen for identification<br />
Rewash EDTA cell suspension<br />
Repeat testing<br />
Confirm patient’s t’ diagnosis, i age, medication,<br />
and pregnancy history<br />
Theory: Weak reacting antigen in the front type.<br />
2
4/12/2011<br />
Types of ERRORS<br />
Clerical Errors<br />
Mislabeled tubes<br />
Patient misidentification<br />
Inaccurate interpretations recorded<br />
Transcription error<br />
Computer entry error<br />
Types of ERRORS<br />
Reagent or equipment problems<br />
Using expired reagents<br />
Using an un-calibrated centrifuge<br />
Contaminated or hemolyzed reagents<br />
Incorrect storage temperatures<br />
Types of ERRORS<br />
<strong>ABO</strong> Discrepancy Categories<br />
Procedural errors<br />
Reagents not added<br />
Manufacturer’s directions not followed<br />
RBC suspensions incorrect concentration<br />
Cell buttons not re-suspended before grading<br />
agglutination<br />
Problems with<br />
Red Blood Cells<br />
Weak-reacting/Missing<br />
antigens<br />
Extra antigens<br />
Mixed field reactions<br />
Problems with<br />
Plasma/Serum<br />
Weak-reacting/Missing<br />
antibodies<br />
Extra antibodies<br />
Grouping<br />
Forward<br />
Reverse<br />
Missing/Weak Extra Mixed Field Missing/Weak Extra<br />
Subgroup A/B Acquired B O Transfusion<br />
Young<br />
Elderly<br />
Immunocompromised<br />
Cold<br />
Autoantibody<br />
tib Forward Grouping Problems<br />
Disease<br />
(cancer)<br />
B(A) Phenotype<br />
Bone Marrow<br />
Transplant<br />
Cold<br />
Alloantibody<br />
Rouleaux<br />
True Chimera<br />
Rouleaux<br />
Anti-A 1<br />
3
4/12/2011<br />
Forward Grouping Problems<br />
Mixed field (mf) agglutination<br />
Weak or missing antigens<br />
Additional or unexpected antigens<br />
Polyagglutinable cells<br />
Forward Grouping Problems<br />
Mixed Field (mf) Reactions<br />
Small agglutinates with many un-agglutinated cells<br />
Result of:<br />
Mixed cell population from a massive transfusion of another blood<br />
group. (non-O individual receiving O red blood cells)<br />
Bone marrow transplants having both the original type and donor<br />
marrow cells.<br />
The inheritance of weak <strong>ABO</strong> subgroups such as A 3 , A x and B 3 and<br />
B can traditionally present a mixed field reaction.<br />
Chimerism due to the intrauterine exchange of red cells, fraternal<br />
twins, and mosaicism arising from dispermy presents mixed field even<br />
though it rarely occurs.<br />
Forward Grouping Problems<br />
Resolving Mixed Field (mf) Reactions<br />
Determine the CAUSE of the mixed field reaction<br />
Checking the patient’s transfusion history and clinical history<br />
e.g. HPC transplant<br />
If it is determined that it is a weak subgroup, perform<br />
specialized tests<br />
e.g. adsorption and elution, saliva, and transferase studies<br />
Molecular testing<br />
Forward Grouping Problems<br />
Weak or Missing Antigen<br />
Result of:<br />
Inheritance of a weak <strong>ABO</strong> subgroup<br />
Malignancies may result in the loss of ABH transferases<br />
Hodgkins disease<br />
Lymphomas<br />
Leukemias<br />
Massive transfusion with group O blood to a non-group O<br />
person<br />
e.g. a group A person receiving lots of group O blood.<br />
Bone marrow transplant and chemotherapy.<br />
Forward Grouping Problems<br />
Resolving Weak or Missing Antigens<br />
Check the patient’s transfusion and clinical history<br />
Read the forward group microscopically<br />
Use anti-A,B and monoclonal antisera that is known to react with<br />
A x and dA 3 weak <strong>ABO</strong> subgroups<br />
Perform adsorption and elution studies<br />
Forward Grouping Problems<br />
Additional Antigens<br />
Result of:<br />
Bacterial enzymes deacetylate the A antigen to a “B”<br />
antigen and the patient front types as an AB and reverses<br />
as an A.<br />
Acquired B antigens are observed in patients with<br />
recurring GI or colon infections with Gram negative<br />
bacteria<br />
4
4/12/2011<br />
Forward Grouping Problems<br />
Resolving Additional Antigens<br />
Check clinical history for evidence of colon infections with<br />
Gram negative sepsis<br />
Test an auto control<br />
The patient’s own anti-B will not react with their own AB cells<br />
Acidify the anti-B to a p.H. of 6 and retest<br />
Acquired B antigens will not react in acidified antiserum,<br />
whereas as normal B antigens will react.<br />
Forward Grouping Problems<br />
Spontaneous Agglutination<br />
Result of:<br />
Strong potent cold auto antibodies<br />
Would appear as AB in the front type and O in the reverse type<br />
Strong positive DAT with IgG, C3d and saline control<br />
Wharton’s jelly in cord blood<br />
Forward Grouping Problems<br />
Resolving Spontaneous Agglutination<br />
Incubate plasma and cells (separately) at 37°C for 5 to<br />
15 minutes<br />
▪ Wash cells 5 to 6 times with warm saline<br />
▪ Retest warm washed cells with warm plasma<br />
▪ Retest the DAT and saline control<br />
Treat cells with 0.01M DTT<br />
Wash cord blood a minimum of 6 times with saline<br />
Forward Grouping Problems<br />
Polyagglutination<br />
Result of:<br />
Inheriting acquired abnormalities of the red cell membranes with<br />
exposure to crypt antigens<br />
e.g. T activation.<br />
Bacterially contaminated sample<br />
Resolve by:<br />
Avoid testing with human antisera; use monoclonal antisera.<br />
Collection of a new sample<br />
Reverse Grouping Problems<br />
▪Plasma or serum <strong>ABO</strong> discrepancies are<br />
more common than red cell discrepancies.<br />
Reverse Grouping Problems<br />
Weak/Missing<br />
Additional Antibodies<br />
Rouleaux<br />
5
4/12/2011<br />
Reverse Grouping Problems<br />
Weak/Missing Antibodies<br />
Newborns<br />
Antibodies are not present at birth and only develop after 3<br />
to 6 months of age.<br />
Elderly<br />
Weakened antibody activity<br />
Hypogammaglobulinemia<br />
Little or no antibody production<br />
(immuno-compromised patient)<br />
NO agglutination on reverse grouping<br />
Reverse Grouping Problems<br />
Resolving Weak/Missing Antibodies<br />
Determine patient’s age and diagnosis<br />
Incubate serum testing for 15 minutes at room<br />
temperature or 18°C to enhance antibody reactions<br />
If negative, incubate serum testing at 4°C for 15<br />
minutes<br />
Reverse Grouping Problems<br />
Extra Antibodies<br />
Result of:<br />
Cold antibodies (allo- or auto-)<br />
Cold antibodies may include anti-I, H, M, N, P, Lewis<br />
Rouleaux<br />
Anti-A 1 in an A 2 or A 2 B individual<br />
Reverse Grouping Problems<br />
Resolving Extra Antibodies: Cold Alloantibodies<br />
Perform antibody identification at IS and or RT<br />
Use the pre-warm technique<br />
Incubate the serum and red cells separately at 37°C before<br />
testing<br />
Perform a cold adsorption<br />
Incubating equal amounts of red cells and serum at 4C for 30 to<br />
60 minutes and test adsorbed serum against reverse type cells<br />
Antigen type reverse cells for the offending antigen<br />
If reverse type cells are antigen positive find reverse type cells<br />
that are antigen negative and incubate with serum to resolve<br />
discrepancy.<br />
Reverse Grouping Problems<br />
Extra Antibodies: Rouleaux<br />
Result of:<br />
Abnormal concentrations of serum proteins<br />
Altered serum/protein ratios<br />
High-molecular-weight volume expanders<br />
Associated with:<br />
‣ Multiple myeloma<br />
‣ Waldenstrom’s macroglobulinemia (WM)<br />
‣ Hydroxyethyl starch (HES), dextran, etc<br />
Reverse Grouping Problems<br />
Resolution of Extra Antibodies: Rouleaux<br />
REMOVE PROTEINS!!<br />
If the forward grouping is affected, wash cells to<br />
remove protein and repeat test<br />
If the reverse grouping is affected, perform saline<br />
replacement technique (more common)<br />
Reagent cells and patient serum are centrifuged to allow<br />
antibody attachment (if present)<br />
Serum is removed and replaced by an equal volume of salinewhich<br />
disperses cells<br />
Tube is mixed, centrifuged, and re-examined for agglutination<br />
6
4/12/2011<br />
Reverse Grouping Problems<br />
Result of:<br />
Extra Antibodies: Anti-A 1<br />
A 2 (or A 2 B) individuals development of anti-A 1 antibody<br />
A 2 (or A 2 B) individuals have less antigen sites than A 1<br />
individuals<br />
anti-A 1 is a naturally occurring IgM antibody<br />
Antibody reacts with A 1 cells, but not A 2 cells<br />
Reverse Grouping Problems<br />
Resolution Extra Antibodies: Anti-A 1<br />
Type patient red blood cells with Anti-A 1 lectin<br />
Test patient serum with A 1 , A 2 and O cells<br />
Case Study #1<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
Case Study #1: Patient History<br />
•88 year old male<br />
•Diagnosis: Immunocompromised<br />
•Medications: Corticosteroids<br />
•Transfusion T f i History: Massive plasma infusion<br />
i<br />
•Lab: Hemoglobin: 6.5 g/dL<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 0 0 0 3+ 0 w+ w+ 0<br />
What is the problem?<br />
Both a front AND reverse typing issue<br />
Both a front AND reverse typing issue<br />
Investigation<br />
Patient age: 88 years old<br />
Diagnosis: Hypogammaglobulinemia<br />
Medications: Immunosuppressive drugs<br />
Resolution:<br />
weak front type, weak reverse type<br />
7
4/12/2011<br />
Weak front type and weak reverse type resolution:<br />
Enhance forward type<br />
Incubate patient cells with antisera (per manufacturers directions)<br />
Enhance reverse type<br />
Incubate reverse type cells with patient serum for 15 to 30 minutes<br />
Room temperature or 18°C (per manufacturers directions)<br />
4°C for 15 minutes<br />
test concurrently with autologous cells and group O screening cells<br />
Enzyme treat reverse type cells with FICIN<br />
Case Study #2<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 0 0 0 3+ 0 w+ w+ 0<br />
30’ RT 0 1+ 2+ 1+ 1+ 0<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
Case Study #2: Patient History<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
• 33 year old female<br />
• Diagnosis: Anemia<br />
• Medications: None<br />
• Transfusion History: 2 units of packed red blood<br />
cells 5 years ago<br />
• Lab: Hemoglobin: 9.1 g/dL<br />
Patient 0 4+ 4+ 3+ 0 3+ 3+ 1+<br />
Screening<br />
Cells<br />
DAT<br />
IS<br />
PEG/IAT<br />
I 1+ 0<br />
II 1+ 0<br />
III 1+ 0<br />
Anti-IgG<br />
Anti-<br />
C3dC3b<br />
Saline<br />
Control<br />
Patient 0 2+ 0<br />
What is the problem?<br />
Reverse typing issue<br />
Additional antibodies: cold??<br />
Investigation<br />
Patient age: 33 years old<br />
Diagnosis: Anemia<br />
Medications: None<br />
Resolution:<br />
Additional antibody in reverse<br />
type<br />
Additional antibody in reverse type resolution:<br />
Prewarm Technique<br />
Incubate the serum and red cells separately at 37°C before testing<br />
Cold Adsorption<br />
Incubate equal amounts of red cells (adsorbing cells) and patient<br />
serum at 4°C for 30 to 60 minutes<br />
Test adsorbed serum against reverse typing cells<br />
Case Study #3<br />
Screening<br />
Cells<br />
IS<br />
4°C Adsorbed<br />
Serum<br />
I 0<br />
II 0<br />
III 0<br />
A 1 cells A 2 cells B cells<br />
Patient 3+ 3+ 1+<br />
4°C<br />
Adsorbed<br />
Serum<br />
3+ 3+ 0<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
8
4/12/2011<br />
Case Study #3: Patient History<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
• 45 year old man<br />
• Diagnosis: Recurrent GI bleed<br />
• Medications: None<br />
• Transfusion History: 10 in past year; none in last<br />
3 months<br />
• Lab: Hemoglobin: 9.2 g/dL<br />
Patient 4+ w+ 4+ 4+ 0 w+ 2+ 3+<br />
Screening<br />
Cells<br />
DAT<br />
IS<br />
PEG/IAT<br />
I 1+ 0<br />
II 1+ 0<br />
III 1+ 0<br />
Anti-IgG<br />
Anti-<br />
C3dC3b<br />
Saline<br />
Control<br />
Patient 0 0 0<br />
What is the problem?<br />
Forward and Reverse typing<br />
issue<br />
Investigation<br />
Patient age: 45 years old<br />
Diagnosis: Recurrent GI bleed<br />
Medications: None<br />
Resolution:<br />
Additional antibody in front<br />
type and reverse type<br />
Additional antibody in the front and reverse type resolution<br />
Forward type:<br />
Wash red cells extensively and repeat testing<br />
Removes proteins<br />
Reverse type<br />
Saline replacement technique;<br />
Patient cells and serum combined and centrifuged<br />
Allows for antigen/antibody reaction (if present)<br />
Remove serum and replace with equal volume of saline<br />
Mix, centrifuge, and reexamine for agglutination<br />
Both macroscopically and microscopically<br />
Front Type:<br />
Anti-A Anti-B Anti-A,B<br />
Patient 4+ w+ 4+<br />
Patient Cells<br />
washed X6<br />
with Saline<br />
4+ 0 4+<br />
Reverse Type:<br />
A 1 cells A 2 cells B cells<br />
Patient w+ 2+ 3+<br />
Saline<br />
Replacement 0 1+ 3+<br />
Screening IS<br />
PEG/IAT<br />
Cells<br />
(saline<br />
replacement)<br />
I w+ 0<br />
II 0 0<br />
III w+ 0<br />
Forward type resolved:<br />
Patient forward type: A<br />
Reverse type NOT resolved:<br />
cold alloantibody??<br />
Anti-M identified at IS<br />
53<br />
54<br />
Reverse grouping cells need to be antigen typed for the M antigen.<br />
A 1 cells<br />
(original source)<br />
A 2 cells<br />
(original source)<br />
B cells<br />
(original source)<br />
A 2 cells<br />
(second source)<br />
B cells<br />
(second source)<br />
Anti-M<br />
0<br />
2+<br />
1+<br />
0<br />
0<br />
•The original source of A 2 and B<br />
cells are M antigen positive. Since<br />
the patient has anti-M identified at<br />
IS, this antigen is interfering with<br />
the reverse grouping (causing a<br />
discrepancy).<br />
•A second source of A 2 and B cells<br />
were located that are M antigen<br />
negative. These cells will be used<br />
to perform reverse grouping on this<br />
patient.<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 4+ w+ 4+ 4+ 0 w+ 2+ 3+<br />
Washed X6 with normal saline<br />
(second source,<br />
M antigen negative)<br />
Saline<br />
replacement<br />
4+ 0 4+ 0 0 3+<br />
9
4/12/2011<br />
Case Study #4: Patient History<br />
Case Study #4<br />
• 36 year old female<br />
• Diagnosis: Pregnancy #3<br />
• Medications: Pre-natal vitamins<br />
• Transfusion History: No transfusions<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
57<br />
58<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 4+ 0 4+ 4+ 0 2+ 0 3+<br />
Screening<br />
Cells<br />
IS<br />
PEG/IAT<br />
I 0 0<br />
II 0 0<br />
III 0 0<br />
What is the problem?<br />
Reverse typing issue<br />
Investigation<br />
Patient age: 36 years old<br />
Diagnosis: Pregnant<br />
Medications: vitamins<br />
Resolution:<br />
Additional antibody in reverse type<br />
•Test the patient’s serum<br />
against different A 1 and A 2<br />
cells<br />
Patient Serum<br />
A 1 cells 3+<br />
A 1 cells 3+<br />
A 1 cells 3+<br />
A 2 cells 0<br />
A 2 cells 0<br />
A 2 cells 0<br />
•Test the patient’s red blood<br />
cells against anti-A 1 lectin<br />
(Dolichos biflorus)<br />
Anti-A 1 Lectin<br />
(Dolichous biflorus)<br />
Patient 0<br />
Resolution: Patient is (probable)<br />
type A 2 with anti-A 1 in her serum<br />
Case Study #5: Patient History<br />
Case Study #5<br />
• 50 year old female<br />
• Diagnosis: COPD<br />
• Medications: Morphine<br />
• Transfusion History: No known transfusion per<br />
blood bank records<br />
• Lab: Hemoglobin: 7.5 g/dL<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
10
4/12/2011<br />
61<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 4+ mf 0 4+ mf 4+ 0 1+ w+ 4+<br />
Screening<br />
Cells<br />
IS<br />
PEG/IAT<br />
Investigation<br />
I 1+ 2+<br />
II 0 0<br />
III 1+ 2+<br />
What is the problem?<br />
Forward and Reverse typing issue<br />
Patient age: 50 years old<br />
Diagnosis: COPD<br />
Medications: Morphine<br />
Resolution:<br />
Mixed field in front type and extra<br />
antibody(ies) in reverse type<br />
Additional antibody in the front and reverse type resolution<br />
Forward type:<br />
Mixed field<br />
What is causing mixed field—has this patient been transfused?<br />
Harvest reticulocytes (that aren’t coated with antibody) and re-test front type<br />
Upon further investigation, patient was transfused with 4 group O<br />
Positive units last week at a different facility (explaining the mixed field<br />
reactivity identified in the front type). The antibody screen was negative<br />
at that time.<br />
Anti-A Anti-B Anti-A,B<br />
Reticulocyte Separation Cells<br />
Patient 4+ 0 4+<br />
A 2 cells<br />
2+<br />
64<br />
63<br />
Reverse type<br />
Antibody identification<br />
What antibody is in the screen?<br />
Could it be interfering with the reverse type?<br />
An elution of the patient’s red blood cells should be performed to<br />
Reverse type resolution:<br />
Antigen type the reverse group RBCs for Jk a to determine if the<br />
antibody is interfering with <strong>ABO</strong> resolution<br />
Absorb the anti-Jk a out of the patient sample and re-test the<br />
serum with the reverse type cells to resolve the <strong>ABO</strong>.<br />
identify the antibody that is coating the red blood cells (positive auto-<br />
control)<br />
Anti-Jk a<br />
Elution of the patient’s red blood cells identifies anti-Jk a is coating<br />
the cells.<br />
Antibody identification in the serum identifies anti-Jk a A 1 cells<br />
(original source)<br />
2+<br />
(original source)<br />
B cells<br />
2+<br />
(original source)<br />
65<br />
Since the patient has been recently transfused, differential adsorptions<br />
are performed at a cold temperature to fully remove the anti-Jk a from<br />
the patient serum.<br />
A 1<br />
cells<br />
A 2<br />
cells<br />
B<br />
cells<br />
Patient 1+ w+ 4+<br />
Adsorbed serum<br />
0 0 4+<br />
Case Study #6<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient 4+ mf 0 4+ mf 4+ 0 1+ w+ 4+<br />
Reticulocyte Separation Cells<br />
Adsorbed serum<br />
4+ 0 4+ 0 0 4+<br />
The need is constant.<br />
The gratification is instant.<br />
Give blood. TM<br />
11
4/12/2011<br />
68<br />
Case Study #6: Patient History<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
• 73 year old male<br />
• Diagnosis: Lymphoma and severe anemia<br />
• Medications: Aspirin<br />
• Transfusion History: 3 units 6 months ago<br />
• Laboratory: Hemoglobin: 4.5 g/dL<br />
• 4 units requested STAT!!<br />
Patient w+ 4+ 4+ 4+ w+ 4+ 2+ 0<br />
Screening<br />
Cells<br />
IS<br />
PEG/IAT<br />
I 0 0<br />
II 0 0<br />
III 0 0<br />
Auto 1+ 3+<br />
DAT<br />
Anti-IgG<br />
Anti-<br />
C3dC3b<br />
Saline<br />
Control<br />
Patient 3+ 2+ w+<br />
What is the problem?<br />
Forward typing issue<br />
Investigation<br />
Patient age: 73 years old<br />
Diagnosis: Lymphoma<br />
Medications: Aspirin<br />
Resolution:<br />
Weak reactive front type,<br />
positive D control, positive<br />
saline control<br />
69<br />
70<br />
Forward type:<br />
Weak Reactivity<br />
Weak <strong>ABO</strong> subgroup? Malignancy? Spontaneous agglutination?<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
Patient w+ 4+ 4+ 4+ w+<br />
Warm washed cells<br />
w+ 4+ 4+ 4+ w+<br />
DAT<br />
Anti-IgG<br />
Anti-<br />
C3dC3b<br />
Saline<br />
Control<br />
Patient 3+ 2+ w+<br />
Warm washed cells<br />
1+ w+ w+<br />
Spontaneous agglutination was not resolved with warm washed cells.<br />
DTT (0.01M) treatment of the red blood cells should be performed to<br />
resolve the <strong>ABO</strong>/Rh discrepancy and disperse the spontaneous<br />
agglutination.<br />
Anti-A Anti-B Anti-A,B Anti-D<br />
D<br />
Control<br />
A 1 cells A 2 cells B cells<br />
Patient w+ 4+ 4+ 4+ w+ 4+ 2+ 0<br />
Warm washed cells<br />
w+ 4+ 4+ 4+ w+<br />
0.01 M DTT Treated Cells<br />
0 4+ 4+ 4+ 0<br />
71<br />
72<br />
DAT<br />
Anti-IgG<br />
Anti-<br />
C3dC3b<br />
Saline<br />
Control<br />
Patient 3+ 2+ w+<br />
Warm washed cells<br />
1+ w+ w+<br />
0.01 M DTT treated Cells<br />
1+ w+ 0<br />
Resolution:<br />
•Patient is B Positive<br />
•Positive DAT and autocontrol was further investigated by a reference<br />
laboratory, and it was discovered the patient had a warm autoantibody<br />
in his plasma.<br />
<strong>ABO</strong> discrepancy recognition AND resolution is<br />
imperative in the blood bank.<br />
<strong>ABO</strong> discrepancies can present themselves as a<br />
front type problem, reverse type problem, or<br />
combination of both.<br />
If <strong>ABO</strong> discrepancy resolution cannot be performed,<br />
and blood is needed immediately, transfusion of<br />
type O blood may be necessary.<br />
12
4/12/2011<br />
73<br />
References<br />
• Harmening, D.M. (2005). Modern Blood Banking and Transfusion<br />
Practices (5 th Ed.)<br />
• Roback, John et.al. Technical Manual, 16th Edition. City: American<br />
Association of Blood Banks (AABB), 2008.<br />
• American Red Cross: <strong>ABO</strong> Discrepancy Standard Operating<br />
Procedure<br />
• Community Blood Bank: University of Texas at Galveston Specialist<br />
in Blood Bank: <strong>ABO</strong> <strong>Discrepancies</strong>.<br />
13